CEs: 6.0, including 4.5 toward pharmacotherapeutic CE requirement (pending)
Join us on Saturday, March 28, 2020, from 8:30 a.m.-4:45 p.m. Stay after the conference for our Member Reception, with award presentations, door prizes, refreshments, and more!
Located on the campus of Bastyr University, 14500 Juanita Dr. NE, Kenmore, WA
Take advantage of early-bird pricing! Save $20 by registering by January 31, 2020.
Join AAPPN today and qualify to receive Member registration rates.
● Members: $170
● Student Members: $100
● Nonmembers: $230
About the Conference
Your registration includes CEs, all materials, refreshments, and a delicious lunch. You’ll also enjoy a space for networking with your colleagues, exhibitor tables, and a post-conference reception featuring member awards, door prizes, and libations.
Exhibitors: Reserve your exhibit space now. Space available for both commercial and nonprofit/government exhibitors. Download an exhibitor application form.
About the Program
Helping clients struggling with treatment-resistant depression is one of the most difficult challenges in our practice. Explore the full spectrum of treatment considerations and modalities that psychiatric nurse practitioners utilize to treat these clients optimally.
Sessions will offer new information, research support, methods, and tools. We will take an in-depth look at this issue from a number of unique perspectives, including:
“The Five D’s of Treatment-Resistant Depression”
David Dunner, MD
Learn to develop a rational treatment plan, including an algorithm you can follow. Discuss the concept of “durability of response” and the Five D’s of treatment-resistant depression.
Dr. Dunner has spent several decades treating patients with treatment-resistant mood disorders, as well as conducting research in treatment resistant depression. He is the Director of the Center for Anxiety and Depression on Mercer Island, and is a Professor Emeritus of the Department of Psychiatry and Behavioral Sciences at the University of Washington.
“Brain Stimulation in Psychiatry: ECT, TMS, and Beyond”
Rebecca Allen, MD, MPH
Explore the clinical criteria, relative efficacy, and common side effects of ECT and TMS, including mechanisms of action, efficacy, tolerability, and when and how to refer.
Dr. Allen is the Director of Neuropsychiatry and Research at Seattle Neuropsychiatric Treatment Center (SeattleNTC), the largest provider of psychiatric brain stimulation services (ECT, TMS, DBS, VNS) in the Pacific Northwest. As a Clinical Assistant Professor at the UW Department of Psychiatry, Dr. Allen serves as a site training director for the Brain Stimulation Psychiatry elective for UW psychiatry residents.
Additional speakers to be announced soon.
This activity has been submitted to Oregon Nurses Association for approval to award contact hours. Oregon Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Upon approval, attendees may earn 6 contact hours, of which 4.5 can be applied toward the pharmacotherapeutic continuing education requirement for advanced practice nurses with prescriptive authority. Participants must be present for all of the educational activity to receive contact hours.
Melanie Kristoferson, MSN, ARNP, PMHNP-BC, Chair
Deborah Eti, PhD, MSN
Bernadette Gilroy, MN, ARNP
Erika Giraldo, DNP, ARNP
Mary Ellen O’Keefe, MN, MBA, PNHCNS-BC, ARNP
Jinn Schladweiler, MN, OEHN, PMHNP, ARNP
Soonja Tyrrell, MSN, ARNP, PMHNP-BC
Patricia Wuertzer, MSN, ARNP-BC, PLLC